Dr. Dr. Leif S. Ludwig

Berlin Insti­tute of Health

Charité Univer­sitätsmedi­zin

Max-Delbrück-Center/Ber­lin Insti­tute of Medical Systems Biology

Leif S. Ludwig is an Emmy Noether-group leader in the focus area Single cell approaches for person­al­ized medicine of the Berlin Insti­tute of Health, the Charité Univer­sitätsmedi­zin and the Max-Delbrück-Center/Ber­lin Insti­tute of Medical Systems Biology.

His research lies at the inter­face of hematol­ogy, human genet­ics and single cell genomics. He special­izes in the devel­op­ment and appli­ca­tion of single cell multi-omic approaches, for example, to quantify the stem cell activ­i­ties in the context of human hematopoiesis. Related to this is the goal of devel­op­ing a deeper under­stand­ing of how mitochon­dr­ial DNA mutations contribute to human mutations contribute to human diseases.

He won multi­ple wards, includ­ing the Broad­Ig­nite Award, the Elisa­beth-Gateff Award and the MINT Excel­lence Award. He has also been awarded the Paul Ehrlich and Ludwig Darmstaedter Young Inves­ti­ga­tor Prize, the Heinz Maier-Leibnitz Prize of the DFG, and has been recog­nized as an EMBO Young Inves­ti­ga­tor (2024). He received research support by the Boehringer Ingel­heim Fonds and the German Acade­mic Schol­ar­ship Founda­tion and more recently an Emmy Noether Fellow­ship by the German Research Founda­tion (DFG).